DPF3, A Putative Candidate Gene For Melanoma Etiopathogenesis in Gray Horses.

This research explores the genetic background of higher melanoma prevalence in gray horses, proposing DPF3 as a potential candidate gene related to the pathogenesis of this condition.

Overview of the Research

• This study focuses on understanding the genetic predisposition of melanoma seen in gray horses. Despite existing research pointing towards a 4.6 kb duplication in the intron 6 of STX17 gene contributing to this predisposition, the key genetic factors responsible for the differences in the development and progression of equine dermal melanomatosis (skin melanomas in horses) remain unclear.
• The researchers conducted a genome-wide association analysis in 141 Lipizzan horses to further explore this issue.

Key Findings

• From the genome-wide study, a potential candidate gene on chromosome 24 named DPF3 was identified, which is presumed to have a role in melanoma pathogenesis in gray horses.
• The associated SNP (single nucleotide polymorphism), a variation occurring at a single position in a DNA sequence, was located in the intronic (non-protein coding) region of DPF3.
• In humans, DPF3 is known to be involved in cell growth, proliferation, apoptosis (cell death), and the motility (ability to move independently) of cancer cells.

Replication Study and Conclusions

• This initial finding was substantiated by a replication study conducted in 1210 horses from seven different breeds. The study found that the G/G genotype of the DPF3-associated SNP may potentially suppress melanoma.
• From these findings, the researchers concluded that DPF3 could be a key gene playing a crucial role in the ability of gray horses to handle a high genetic load of melanoma-related tumors.